The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER

NCT07502820 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1100

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Adjuvant Drug Therapy

Interventions

DRUG: Individual dose of tamoxifen
DRUG: Standard adjuvant therapy of tamoxifen

Sponsor

Karolinska Institutet

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]